Authors
Melina Arnold, Mark J Rutherford, Aude Bardot, Jacques Ferlay, Therese ML Andersson, Tor Åge Myklebust, Hanna Tervonen, Vicky Thursfield, David Ransom, Lorraine Shack, Ryan R Woods, Donna Turner, Suzanne Leonfellner, Susan Ryan, Nathalie Saint-Jacques, Prithwish De, Carol McClure, Agnihotram V Ramanakumar, Heather Stuart-Panko, Gerda Engholm, Paul M Walsh, Christopher Jackson, Sally Vernon, Eileen Morgan, Anna Gavin, David S Morrison, Dyfed W Huws, Geoff Porter, John Butler, Heather Bryant, David C Currow, Sara Hiom, D Max Parkin, Peter Sasieni, Paul C Lambert, Bjørn Møller, Isabelle Soerjomataram, Freddie Bray
Publication date
2019/11/1
Journal
The Lancet Oncology
Volume
20
Issue
11
Pages
1493-1505
Publisher
Elsevier
Description
Background
Population-based cancer survival estimates provide valuable insights into the effectiveness of cancer services and can reflect the prospects of cure. As part of the second phase of the International Cancer Benchmarking Partnership (ICBP), the Cancer Survival in High-Income Countries (SURVMARK-2) project aims to provide a comprehensive overview of cancer survival across seven high-income countries and a comparative assessment of corresponding incidence and mortality trends.
Methods
In this longitudinal, population-based study, we collected patient-level data on 3·9 million patients with cancer from population-based cancer registries in 21 jurisdictions in seven countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the UK) for seven sites of cancer (oesophagus, stomach, colon, rectum, pancreas, lung, and ovary) diagnosed between 1995 and 2014, and followed up until …
Scholar articles
M Arnold, MJ Rutherford, A Bardot, J Ferlay… - The Lancet Oncology, 2019